2-43822924-G-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_022436.3(ABCG5):c.1336C>T(p.Arg446*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00011 in 1,613,826 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.00012 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00011 ( 1 hom. )
Consequence
ABCG5
NM_022436.3 stop_gained
NM_022436.3 stop_gained
Scores
2
4
1
Clinical Significance
Conservation
PhyloP100: 5.11
Genes affected
ABCG5 (HGNC:13886): (ATP binding cassette subfamily G member 5) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the White subfamily. The protein encoded by this gene functions as a half-transporter to limit intestinal absorption and promote biliary excretion of sterols. It is expressed in a tissue-specific manner in the liver, colon, and intestine. This gene is tandemly arrayed on chromosome 2, in a head-to-head orientation with family member ABCG8. Mutations in this gene may contribute to sterol accumulation and atheroschlerosis, and have been observed in patients with sitosterolemia. [provided by RefSeq, Jul 2008]
DYNC2LI1 (HGNC:24595): (dynein cytoplasmic 2 light intermediate chain 1) This gene encodes a protein that is a component of the dynein-2 microtubule motor protein complex that plays a role in the retrograde transport of cargo in primary cilia via the intraflagellar transport system. This gene is ubiquitously expressed and its protein, which localizes to the axoneme and Golgi apparatus, interacts directly with the cytoplasmic dynein 2 heavy chain 1 protein to form part of the multi-protein dynein-2 complex. Mutations in this gene produce defects in the dynein-2 complex which result in several types of ciliopathy including short-rib thoracic dysplasia 15 with polydactyly (SRTD15). Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Feb 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 2-43822924-G-A is Pathogenic according to our data. Variant chr2-43822924-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 30485.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-43822924-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABCG5 | NM_022436.3 | c.1336C>T | p.Arg446* | stop_gained | 10/13 | ENST00000405322.8 | NP_071881.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCG5 | ENST00000405322.8 | c.1336C>T | p.Arg446* | stop_gained | 10/13 | 1 | NM_022436.3 | ENSP00000384513.2 | ||
ABCG5 | ENST00000486512.5 | n.1857C>T | non_coding_transcript_exon_variant | 6/9 | 1 | |||||
ABCG5 | ENST00000409962.1 | n.1619C>T | non_coding_transcript_exon_variant | 6/9 | 2 | |||||
ABCG5 | ENST00000644754.1 | n.1720C>T | non_coding_transcript_exon_variant | 7/10 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152042Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
19
AN:
152042
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000179 AC: 45AN: 250704Hom.: 0 AF XY: 0.000177 AC XY: 24AN XY: 135580
GnomAD3 exomes
AF:
AC:
45
AN:
250704
Hom.:
AF XY:
AC XY:
24
AN XY:
135580
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000109 AC: 159AN: 1461668Hom.: 1 Cov.: 33 AF XY: 0.000127 AC XY: 92AN XY: 727128
GnomAD4 exome
AF:
AC:
159
AN:
1461668
Hom.:
Cov.:
33
AF XY:
AC XY:
92
AN XY:
727128
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000125 AC: 19AN: 152158Hom.: 0 Cov.: 31 AF XY: 0.0000941 AC XY: 7AN XY: 74380
GnomAD4 genome
AF:
AC:
19
AN:
152158
Hom.:
Cov.:
31
AF XY:
AC XY:
7
AN XY:
74380
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
18
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:18
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Sitosterolemia 2 Pathogenic:6
Pathogenic, criteria provided, single submitter | clinical testing | New York Genome Center | May 25, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Sep 20, 2023 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 15, 2010 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Aug 28, 2020 | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 26, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 14, 2021 | - - |
not provided Pathogenic:5
Pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Feb 21, 2024 | PP1_strong, PM3_very_strong, PVS1 - |
Pathogenic, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 28, 2022 | Observed with a variant on the opposite allele (in trans) in in patients with sitosterolemia in published literature (Kratz et al., 2007; Rios et al., 2010; Wang et al., 2014; Buonuomo et al., 2017; Hu et al., 2021); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 21729603, 27884173, 26813946, 34426522, 25525159, 31589614, 32041611, 32862661, 20521169, 17228349, 19111681, 30528907, 29055934, 28521186, 25665839, 33217533, 29353225, 33269076, 17976197, 24166850, 20719861, 31060161) - |
Pathogenic, criteria provided, single submitter | clinical testing | AiLife Diagnostics, AiLife Diagnostics | Oct 20, 2021 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Sitosterolemia Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | The ABCG5 c.1336C>T (p.Arg446Ter) variant is a stop-gained variant that has been reported in seven studies in which it is found in a total of 11 individuals with sitosterolemia, including four in a homozygous state (of which three are related) and six in a compound heterozygous state. The variant was also detected in a compound heterozygous state in an asymptomatic sibling (Mannucci et al. 2007; Kratz et al. 2007; Nui et al. 2010; Rios et al. 2010; Park et al. 2014; Tada et al. 2015; Li et al. 2016). Control data are unavailable for the p.Arg446Ter variant, which is reported at a frequency of 0.00071 in the East Asian population of the Exome Aggregation Consortium. Due to the potential impact of stop-gained variants and the supporting evidence, the p.Arg446Ter variant is classified as pathogenic for sitosterolemia. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Pathogenic, criteria provided, single submitter | research | Pediatric Genetics Division, Center for Pediatrics and Adolescent Medicine, University Medical Center Freiburg | Sep 01, 2013 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 17, 2023 | This sequence change creates a premature translational stop signal (p.Arg446*) in the ABCG5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ABCG5 are known to be pathogenic (PMID: 11138003, 25665839). This variant is present in population databases (rs199689137, gnomAD 0.08%). This premature translational stop signal has been observed in individual(s) with sitosterolemia (PMID: 34304999, 34887220, 34969652). ClinVar contains an entry for this variant (Variation ID: 30485). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 06, 2018 | The p.Arg446X variant in ABCG5 has been reported in at least 10 individuals with sitosterolemia, all of whom were homozygous or compound heterozygous, and segre gated with disease in 7 affected family members from 4 families (Kratz 2007, Man nucci 2007, Togo 2009, Rios 2010, Niu 2010, Wang 2011, Park 2014, Wang 2014, Tad a 2015, Li 2016, Pek 2017, Buonuomo 2017, Fang 2018). This variant has also been identified in 0.09% (16/18858) of East Asian chromosomes by gnomAD (http://gnom ad.broadinstitute.org). However, this frequency is low enough to be consistent w ith a recessive carrier frequency. This nonsense variant leads to a premature te rmination codon at position 446, which is predicted to lead to a truncated or ab sent protein. Loss of function of the ABCG5 gene is an established disease mecha nism in autosomal recessive sitosterolemia; however, this condition is known to have variable expressivity and reduced penetrance. In summary, this variant meet s criteria to be classified as pathogenic for autosomal recessive sitosterolemia based on case observations, segregation studies, and predicted impact on protei n. ACMG/AMP criteria applied: PVS1, PM3_VeryStrong, PP1_Strong. - |
Sitosterolemia 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Molecular Genetics, Royal Melbourne Hospital | Apr 22, 2022 | This sequence change creates a premature termination codon at position 446 in exon 10 (of 13) of ABCG5 (p.Arg446*). It is expected to result in an absent or disrupted protein product. Loss of function is an established mechanism of disease for ABCG5 in autosomal recessive sitosterolaemia (PVS1). It is present in a large population cohort at a frequency of 0.02% (rs199689137, 48/282,080 alleles in gnomAD v2.1.1), and is most prevalent in the East Asian population with a frequency of 0.09% (17/19,940 alleles). The variant has been reported in multiple individuals diagnosed with sitosterolaemia, all of whom were homozygous or compound heterozygous with a second pathogenic variant in ABCG5 (PMID: 19111681, 20719861, 24166850, 26813946, 28521186 - PM3_VeryStrong), and segregated in affected family members in multiple families (PMID: 17976197, 24166850 - PP1_Strong). Based on the classification scheme RMH ACMG Guidelines v1.1.1, this variant is classified as PATHOGENIC. Following criteria are met: PVS1, PM3_VeryStrong, PP1_Strong. - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 01, 2023 | The c.1336C>T (p.R446*) alteration, located in exon 10 (coding exon 10) of the ABCG5 gene, consists of a C to T substitution at nucleotide position 1336. This changes the amino acid from an arginine (R) to a stop codon at amino acid position 446. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from gnomAD, the T allele has an overall frequency of 0.017% (48/282080) total alleles studied. The highest observed frequency was 0.085% (17/19940) of East Asian alleles. This variant has been reported in the homozygous and compound heterozygous states in multiple individuals and families affected with sitosterolemia (Mannucci, 2007; Niu, 2010; Wang, 2014; Bazerbachi, 2017; Buonuomo, 2017; Veit, 2019; Wang, 2019; Frederiksen, 2021; Kaya, 2021; Zhang, 2022; Xia, 2022). Based on the available evidence, this alteration is classified as pathogenic. - |
Short-rib thoracic dysplasia 15 with polydactyly Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 26, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
Vest4
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at